✦ LIBER ✦

Design of ICAM-1-Targeting Strategies for Brain Delivery of Lysosomal Therapies

✍ Scribed by Silvia Muro; Janet Hsu; Tridib Bhowmick; Carmen Garnacho; Silvia Muro

Book ID: 116989202
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 56 KB
Volume: 102
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2010.11.106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhanced delivery of α-glucosidase for P

Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders

✍ Janet Hsu; Laura Northrup; Tridib Bhowmick; Silvia Muro 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 774 KB

Comparative binding, endocytosis, and bi

Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor

✍ Papademetriou, Jason; Garnacho, Carmen; Serrano, Daniel; Bhowmick, Tridib; Schuc 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 352 KB

Genetic engineering of a lysosomal enzym

Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier

✍ Ruben J. Boado; Yun Zhang; Yufeng Zhang; Chun-fang Xia; Yuntao Wang; William M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

## Abstract Mucopolysaccharidosis Type I, Hurler's Syndrome, is a lysosomal storage disorder that affects the brain. The missing enzyme, α‐L‐iduronidase (IDUA), does not cross the blood‐brain barrier (BBB). To enable BBB transport of the enzyme, human IDUA was fused to the carboxyl terminus of the

Trial Design Strategies for Vascular-Tar

Trial Design Strategies for Vascular-Targeted Therapy of Patients with Ovarian Cancer

✍ Mohini A. Varughese; Jonathan A. Ledermann 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

Convection enhanced delivery of boronate

Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors

✍ Weilian Yang; Rolf F. Barth; Gong Wu; Tianyao Huo; Werner Tjarks; Michael Ciesie 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 388 KB

New strategies for targeting the therapy

New strategies for targeting the therapy of NSCLC: the role of ERCC1 and TS

✍ Ceppi, P; Papotti, M; Scagliotti, G 📂 Article 📅 2010 🏛 Versita 🌐 English ⚖ 140 KB